Cytonet Recognizes Rare Disease Day with Efforts to Help Ensure UCD Diagnoses Are Not Missed

Market Watch

HEIDELBERG, Germany, Feb. 27, 2012 /PRNewswire via COMTEX/ -- For parents of babies born with urea cycle disorders (UCD), the joy of giving birth to a perfect baby can quickly turn to devastation as the baby's health rapidly declines, going from symptoms such as being tired and irritable, to not eating, to experiencing seizures and coma. UCDs are congenital and often life-threatening disorders of ammonia metabolism in the liver that cause neurotoxic ammonia to accumulate in the body, potentially leading to massive damage of the nerves and the brain and death.

UCDs are one of more than 7,000 rare diseases. In recognition of Rare Disease Day on February 29, international biotechnology firm Cytonet is taking several actions to help make a difference for people affected by UCD. "Cytonet is deeply committed to improving the lives of people with UCD," says Dr. Wolfgang Rudinger, CEO and CSO of Cytonet Germany. "It is critical that symptoms are recognized and a diagnosis of UCD is made as quickly as possible to give these children the best chance, so we are helping educate healthcare professionals and the public about UCD." Activities include:

Cytonet sponsored the newly released' "Physician's Guide to Urea Cycle Disorders," published by the National Organization for Rare Disorders (NORD) to educate healthcare professionals about symptoms, making the diagnosis and treatment.

Cytonet produced a short video for medical professionals about UCD and a clinical trial for liver cell therapy, which is currently enrolling patients.